 | • レポートコード：MRC2-11QY08403 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は経口造影剤のグローバル市場について調査・分析したレポートです。種類別（バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤）市場規模、用途別（心血管障害、がん、胃腸障害、筋骨格系障害、神経障害、腎障害）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口造影剤の競争状況、市場シェア ・世界の経口造影剤市場：種類別市場規模 2015年-2020年（バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤） ・世界の経口造影剤市場：種類別市場規模予測 2021年-2026年（バリウムベース造影剤、ヨウ素化造影剤、ガドリニウムベース造影剤、マイクロバブル造影剤） ・世界の経口造影剤市場：用途別市場規模 2015年-2020年（心血管障害、がん、胃腸障害、筋骨格系障害、神経障害、腎障害） ・世界の経口造影剤市場：用途別市場規模予測 2021年-2026年（心血管障害、がん、胃腸障害、筋骨格系障害、神経障害、腎障害） ・北米の経口造影剤市場分析：米国、カナダ ・ヨーロッパの経口造影剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口造影剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口造影剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口造影剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：GE Healthcare (US)、Bracco Imaging (Italy)、Bayer HealthCare (Germany)、Guerbet (France)、Lantheus (US)、Daiichi Sankyo (Japan)、Unijules Life Sciences (India)、J.B. Chemicals and Pharmaceuticals (India)、Spago Nanomedicine (Sweden)、Taejoon Pharm (South Korea)、Jodas (India)、Magnus Health (India) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Oral Contrast Agent Market
The global Oral Contrast Agent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Oral Contrast Agent Scope and Market Size
Oral Contrast Agent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contrast Agent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Contrast Agent market is segmented into
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segment by Application, the Oral Contrast Agent market is segmented into
Cardiovascular Disorders
Cancer
Gastrointestinal Disorders
Musculoskeletal Disorders
Neurological Disorders
Nephrological Disorders
Regional and Country-level Analysis
The Oral Contrast Agent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Contrast Agent market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Contrast Agent Market Share Analysis
Oral Contrast Agent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Contrast Agent business, the date to enter into the Oral Contrast Agent market, Oral Contrast Agent product introduction, recent developments, etc.
The major vendors covered:
GE Healthcare (US)
Bracco Imaging (Italy)
Bayer HealthCare (Germany)
Guerbet (France)
Lantheus (US)
Daiichi Sankyo (Japan)
Unijules Life Sciences (India)
J.B. Chemicals and Pharmaceuticals (India)
Spago Nanomedicine (Sweden)
Taejoon Pharm (South Korea)
Jodas (India)
Magnus Health (India)
1 Study Coverage
1.1 Oral Contrast Agent Product Introduction
1.2 Market Segments
1.3 Key Oral Contrast Agent Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Contrast Agent Market Size Growth Rate by Type
1.4.2 Barium-based Contrast Media
1.4.3 Iodinated Contrast Media
1.4.4 Gadolinium-based Contrast Media
1.4.5 Microbubble Contrast Media
1.5 Market by Application
1.5.1 Global Oral Contrast Agent Market Size Growth Rate by Application
1.5.2 Cardiovascular Disorders
1.5.3 Cancer
1.5.4 Gastrointestinal Disorders
1.5.5 Musculoskeletal Disorders
1.5.6 Neurological Disorders
1.5.7 Nephrological Disorders
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Contrast Agent Market Size, Estimates and Forecasts
2.1.1 Global Oral Contrast Agent Revenue 2015-2026
2.1.2 Global Oral Contrast Agent Sales 2015-2026
2.2 Global Oral Contrast Agent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Contrast Agent Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Contrast Agent Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Contrast Agent Competitor Landscape by Players
3.1 Oral Contrast Agent Sales by Manufacturers
3.1.1 Oral Contrast Agent Sales by Manufacturers (2015-2020)
3.1.2 Oral Contrast Agent Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Contrast Agent Revenue by Manufacturers
3.2.1 Oral Contrast Agent Revenue by Manufacturers (2015-2020)
3.2.2 Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Contrast Agent Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Contrast Agent Revenue in 2019
3.2.5 Global Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Contrast Agent Price by Manufacturers
3.4 Oral Contrast Agent Manufacturing Base Distribution, Product Types
3.4.1 Oral Contrast Agent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Contrast Agent Product Type
3.4.3 Date of International Manufacturers Enter into Oral Contrast Agent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Contrast Agent Market Size by Type (2015-2020)
4.1.1 Global Oral Contrast Agent Sales by Type (2015-2020)
4.1.2 Global Oral Contrast Agent Revenue by Type (2015-2020)
4.1.3 Oral Contrast Agent Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Contrast Agent Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Contrast Agent Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Contrast Agent Revenue Forecast by Type (2021-2026)
4.2.3 Oral Contrast Agent Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Contrast Agent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Contrast Agent Market Size by Application (2015-2020)
5.1.1 Global Oral Contrast Agent Sales by Application (2015-2020)
5.1.2 Global Oral Contrast Agent Revenue by Application (2015-2020)
5.1.3 Oral Contrast Agent Price by Application (2015-2020)
5.2 Oral Contrast Agent Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Contrast Agent Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Contrast Agent Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Contrast Agent Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Contrast Agent by Country
6.1.1 North America Oral Contrast Agent Sales by Country
6.1.2 North America Oral Contrast Agent Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Contrast Agent Market Facts & Figures by Type
6.3 North America Oral Contrast Agent Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Contrast Agent by Country
7.1.1 Europe Oral Contrast Agent Sales by Country
7.1.2 Europe Oral Contrast Agent Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Contrast Agent Market Facts & Figures by Type
7.3 Europe Oral Contrast Agent Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Contrast Agent by Region
8.1.1 Asia Pacific Oral Contrast Agent Sales by Region
8.1.2 Asia Pacific Oral Contrast Agent Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Contrast Agent Market Facts & Figures by Type
8.3 Asia Pacific Oral Contrast Agent Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Contrast Agent by Country
9.1.1 Latin America Oral Contrast Agent Sales by Country
9.1.2 Latin America Oral Contrast Agent Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Contrast Agent Market Facts & Figures by Type
9.3 Central & South America Oral Contrast Agent Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Contrast Agent by Country
10.1.1 Middle East and Africa Oral Contrast Agent Sales by Country
10.1.2 Middle East and Africa Oral Contrast Agent Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Type
10.3 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Application
11 Company Profiles
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Description and Business Overview
11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered
11.1.5 GE Healthcare (US) Related Developments
11.2 Bracco Imaging (Italy)
11.2.1 Bracco Imaging (Italy) Corporation Information
11.2.2 Bracco Imaging (Italy) Description and Business Overview
11.2.3 Bracco Imaging (Italy) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bracco Imaging (Italy) Oral Contrast Agent Products Offered
11.2.5 Bracco Imaging (Italy) Related Developments
11.3 Bayer HealthCare (Germany)
11.3.1 Bayer HealthCare (Germany) Corporation Information
11.3.2 Bayer HealthCare (Germany) Description and Business Overview
11.3.3 Bayer HealthCare (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer HealthCare (Germany) Oral Contrast Agent Products Offered
11.3.5 Bayer HealthCare (Germany) Related Developments
11.4 Guerbet (France)
11.4.1 Guerbet (France) Corporation Information
11.4.2 Guerbet (France) Description and Business Overview
11.4.3 Guerbet (France) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Guerbet (France) Oral Contrast Agent Products Offered
11.4.5 Guerbet (France) Related Developments
11.5 Lantheus (US)
11.5.1 Lantheus (US) Corporation Information
11.5.2 Lantheus (US) Description and Business Overview
11.5.3 Lantheus (US) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Lantheus (US) Oral Contrast Agent Products Offered
11.5.5 Lantheus (US) Related Developments
11.6 Daiichi Sankyo (Japan)
11.6.1 Daiichi Sankyo (Japan) Corporation Information
11.6.2 Daiichi Sankyo (Japan) Description and Business Overview
11.6.3 Daiichi Sankyo (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Daiichi Sankyo (Japan) Oral Contrast Agent Products Offered
11.6.5 Daiichi Sankyo (Japan) Related Developments
11.7 Unijules Life Sciences (India)
11.7.1 Unijules Life Sciences (India) Corporation Information
11.7.2 Unijules Life Sciences (India) Description and Business Overview
11.7.3 Unijules Life Sciences (India) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Unijules Life Sciences (India) Oral Contrast Agent Products Offered
11.7.5 Unijules Life Sciences (India) Related Developments
11.8 J.B. Chemicals and Pharmaceuticals (India)
11.8.1 J.B. Chemicals and Pharmaceuticals (India) Corporation Information
11.8.2 J.B. Chemicals and Pharmaceuticals (India) Description and Business Overview
11.8.3 J.B. Chemicals and Pharmaceuticals (India) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Products Offered
11.8.5 J.B. Chemicals and Pharmaceuticals (India) Related Developments
11.9 Spago Nanomedicine (Sweden)
11.9.1 Spago Nanomedicine (Sweden) Corporation Information
11.9.2 Spago Nanomedicine (Sweden) Description and Business Overview
11.9.3 Spago Nanomedicine (Sweden) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Products Offered
11.9.5 Spago Nanomedicine (Sweden) Related Developments
11.10 Taejoon Pharm (South Korea)
11.10.1 Taejoon Pharm (South Korea) Corporation Information
11.10.2 Taejoon Pharm (South Korea) Description and Business Overview
11.10.3 Taejoon Pharm (South Korea) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Taejoon Pharm (South Korea) Oral Contrast Agent Products Offered
11.10.5 Taejoon Pharm (South Korea) Related Developments
11.1 GE Healthcare (US)
11.1.1 GE Healthcare (US) Corporation Information
11.1.2 GE Healthcare (US) Description and Business Overview
11.1.3 GE Healthcare (US) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GE Healthcare (US) Oral Contrast Agent Products Offered
11.1.5 GE Healthcare (US) Related Developments
11.12 Magnus Health (India)
11.12.1 Magnus Health (India) Corporation Information
11.12.2 Magnus Health (India) Description and Business Overview
11.12.3 Magnus Health (India) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Magnus Health (India) Products Offered
11.12.5 Magnus Health (India) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Contrast Agent Market Estimates and Projections by Region
12.1.1 Global Oral Contrast Agent Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Contrast Agent Revenue Forecast by Regions 2021-2026
12.2 North America Oral Contrast Agent Market Size Forecast (2021-2026)
12.2.1 North America: Oral Contrast Agent Sales Forecast (2021-2026)
12.2.2 North America: Oral Contrast Agent Revenue Forecast (2021-2026)
12.2.3 North America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Contrast Agent Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Contrast Agent Sales Forecast (2021-2026)
12.3.2 Europe: Oral Contrast Agent Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Contrast Agent Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Contrast Agent Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Contrast Agent Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Contrast Agent Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Contrast Agent Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Contrast Agent Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Contrast Agent Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Contrast Agent Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Contrast Agent Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Contrast Agent Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Contrast Agent Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Contrast Agent Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Contrast Agent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Oral Contrast Agent Market Segments
Table 2. Ranking of Global Top Oral Contrast Agent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Contrast Agent Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Barium-based Contrast Media
Table 5. Major Manufacturers of Iodinated Contrast Media
Table 6. Major Manufacturers of Gadolinium-based Contrast Media
Table 7. Major Manufacturers of Microbubble Contrast Media
Table 8. Global Oral Contrast Agent Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Oral Contrast Agent Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Oral Contrast Agent Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Oral Contrast Agent Sales Market Share by Regions (2015-2020)
Table 12. Global Oral Contrast Agent Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Oral Contrast Agent Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Oral Contrast Agent Sales Share by Manufacturers (2015-2020)
Table 15. Global Oral Contrast Agent Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Oral Contrast Agent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Contrast Agent as of 2019)
Table 17. Oral Contrast Agent Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Oral Contrast Agent Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Oral Contrast Agent Price (2015-2020) (USD/Pcs)
Table 20. Oral Contrast Agent Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Oral Contrast Agent Product Type
Table 22. Date of International Manufacturers Enter into Oral Contrast Agent Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 25. Global Oral Contrast Agent Sales Share by Type (2015-2020)
Table 26. Global Oral Contrast Agent Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Oral Contrast Agent Revenue Share by Type (2015-2020)
Table 28. Oral Contrast Agent Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 30. Global Oral Contrast Agent Sales Share by Application (2015-2020)
Table 31. North America Oral Contrast Agent Sales by Country (2015-2020) (K Pcs)
Table 32. North America Oral Contrast Agent Sales Market Share by Country (2015-2020)
Table 33. North America Oral Contrast Agent Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Oral Contrast Agent Revenue Market Share by Country (2015-2020)
Table 35. North America Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 36. North America Oral Contrast Agent Sales Market Share by Type (2015-2020)
Table 37. North America Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 38. North America Oral Contrast Agent Sales Market Share by Application (2015-2020)
Table 39. Europe Oral Contrast Agent Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Oral Contrast Agent Sales Market Share by Country (2015-2020)
Table 41. Europe Oral Contrast Agent Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Oral Contrast Agent Revenue Market Share by Country (2015-2020)
Table 43. Europe Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Oral Contrast Agent Sales Market Share by Type (2015-2020)
Table 45. Europe Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Oral Contrast Agent Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Oral Contrast Agent Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Oral Contrast Agent Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Oral Contrast Agent Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Oral Contrast Agent Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Oral Contrast Agent Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Oral Contrast Agent Sales Market Share by Application (2015-2020)
Table 55. Latin America Oral Contrast Agent Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Oral Contrast Agent Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Oral Contrast Agent Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Oral Contrast Agent Revenue Market Share by Country (2015-2020)
Table 59. Latin America Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Oral Contrast Agent Sales Market Share by Type (2015-2020)
Table 61. Latin America Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Oral Contrast Agent Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Oral Contrast Agent Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Oral Contrast Agent Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oral Contrast Agent Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Oral Contrast Agent Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oral Contrast Agent Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Oral Contrast Agent Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Oral Contrast Agent Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Oral Contrast Agent Sales Market Share by Application (2015-2020)
Table 71. GE Healthcare (US) Corporation Information
Table 72. GE Healthcare (US) Description and Major Businesses
Table 73. GE Healthcare (US) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. GE Healthcare (US) Product
Table 75. GE Healthcare (US) Recent Development
Table 76. Bracco Imaging (Italy) Corporation Information
Table 77. Bracco Imaging (Italy) Description and Major Businesses
Table 78. Bracco Imaging (Italy) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Bracco Imaging (Italy) Product
Table 80. Bracco Imaging (Italy) Recent Development
Table 81. Bayer HealthCare (Germany) Corporation Information
Table 82. Bayer HealthCare (Germany) Description and Major Businesses
Table 83. Bayer HealthCare (Germany) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Bayer HealthCare (Germany) Product
Table 85. Bayer HealthCare (Germany) Recent Development
Table 86. Guerbet (France) Corporation Information
Table 87. Guerbet (France) Description and Major Businesses
Table 88. Guerbet (France) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Guerbet (France) Product
Table 90. Guerbet (France) Recent Development
Table 91. Lantheus (US) Corporation Information
Table 92. Lantheus (US) Description and Major Businesses
Table 93. Lantheus (US) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Lantheus (US) Product
Table 95. Lantheus (US) Recent Development
Table 96. Daiichi Sankyo (Japan) Corporation Information
Table 97. Daiichi Sankyo (Japan) Description and Major Businesses
Table 98. Daiichi Sankyo (Japan) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Daiichi Sankyo (Japan) Product
Table 100. Daiichi Sankyo (Japan) Recent Development
Table 101. Unijules Life Sciences (India) Corporation Information
Table 102. Unijules Life Sciences (India) Description and Major Businesses
Table 103. Unijules Life Sciences (India) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. Unijules Life Sciences (India) Product
Table 105. Unijules Life Sciences (India) Recent Development
Table 106. J.B. Chemicals and Pharmaceuticals (India) Corporation Information
Table 107. J.B. Chemicals and Pharmaceuticals (India) Description and Major Businesses
Table 108. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. J.B. Chemicals and Pharmaceuticals (India) Product
Table 110. J.B. Chemicals and Pharmaceuticals (India) Recent Development
Table 111. Spago Nanomedicine (Sweden) Corporation Information
Table 112. Spago Nanomedicine (Sweden) Description and Major Businesses
Table 113. Spago Nanomedicine (Sweden) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. Spago Nanomedicine (Sweden) Product
Table 115. Spago Nanomedicine (Sweden) Recent Development
Table 116. Taejoon Pharm (South Korea) Corporation Information
Table 117. Taejoon Pharm (South Korea) Description and Major Businesses
Table 118. Taejoon Pharm (South Korea) Oral Contrast Agent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 119. Taejoon Pharm (South Korea) Product
Table 120. Taejoon Pharm (South Korea) Recent Development
Table 121. Jodas (India) Corporation Information
Table 122. Jodas (India) Description and Major Businesses
Table 123. Jodas (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 124. Jodas (India) Product
Table 125. Jodas (India) Recent Development
Table 126. Magnus Health (India) Corporation Information
Table 127. Magnus Health (India) Description and Major Businesses
Table 128. Magnus Health (India) Oral Contrast Agent Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 129. Magnus Health (India) Product
Table 130. Magnus Health (India) Recent Development
Table 131. Global Oral Contrast Agent Sales Forecast by Regions (2021-2026) (K Pcs)
Table 132. Global Oral Contrast Agent Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Oral Contrast Agent Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Oral Contrast Agent Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Oral Contrast Agent Sales Forecast by Country (2021-2026) (K Pcs)
Table 136. North America: Oral Contrast Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Oral Contrast Agent Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. Europe: Oral Contrast Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Oral Contrast Agent Sales Forecast by Region (2021-2026) (K Pcs)
Table 140. Asia Pacific: Oral Contrast Agent Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Oral Contrast Agent Sales Forecast by Country (2021-2026) (K Pcs)
Table 142. Latin America: Oral Contrast Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Oral Contrast Agent Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. Middle East and Africa: Oral Contrast Agent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Oral Contrast Agent Players
Table 149. Oral Contrast Agent Customers List
Table 150. Oral Contrast Agent Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Contrast Agent Product Picture
Figure 2. Global Oral Contrast Agent Sales Market Share by Type in 2020 & 2026
Figure 3. Barium-based Contrast Media Product Picture
Figure 4. Iodinated Contrast Media Product Picture
Figure 5. Gadolinium-based Contrast Media Product Picture
Figure 6. Microbubble Contrast Media Product Picture
Figure 7. Global Oral Contrast Agent Sales Market Share by Application in 2020 & 2026
Figure 8. Cardiovascular Disorders
Figure 9. Cancer
Figure 10. Gastrointestinal Disorders
Figure 11. Musculoskeletal Disorders
Figure 12. Neurological Disorders
Figure 13. Nephrological Disorders
Figure 14. Oral Contrast Agent Report Years Considered
Figure 15. Global Oral Contrast Agent Market Size 2015-2026 (US$ Million)
Figure 16. Global Oral Contrast Agent Sales 2015-2026 (K Pcs)
Figure 17. Global Oral Contrast Agent Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Oral Contrast Agent Sales Market Share by Region (2015-2020)
Figure 19. Global Oral Contrast Agent Sales Market Share by Region in 2019
Figure 20. Global Oral Contrast Agent Revenue Market Share by Region (2015-2020)
Figure 21. Global Oral Contrast Agent Revenue Market Share by Region in 2019
Figure 22. Global Oral Contrast Agent Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Oral Contrast Agent Revenue in 2019
Figure 24. Oral Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Oral Contrast Agent Sales Market Share by Type (2015-2020)
Figure 26. Global Oral Contrast Agent Sales Market Share by Type in 2019
Figure 27. Global Oral Contrast Agent Revenue Market Share by Type (2015-2020)
Figure 28. Global Oral Contrast Agent Revenue Market Share by Type in 2019
Figure 29. Global Oral Contrast Agent Market Share by Price Range (2015-2020)
Figure 30. Global Oral Contrast Agent Sales Market Share by Application (2015-2020)
Figure 31. Global Oral Contrast Agent Sales Market Share by Application in 2019
Figure 32. Global Oral Contrast Agent Revenue Market Share by Application (2015-2020)
Figure 33. Global Oral Contrast Agent Revenue Market Share by Application in 2019
Figure 34. North America Oral Contrast Agent Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Oral Contrast Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Oral Contrast Agent Sales Market Share by Country in 2019
Figure 37. North America Oral Contrast Agent Revenue Market Share by Country in 2019
Figure 38. U.S. Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Oral Contrast Agent Market Share by Type in 2019
Figure 43. North America Oral Contrast Agent Market Share by Application in 2019
Figure 44. Europe Oral Contrast Agent Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Oral Contrast Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Oral Contrast Agent Sales Market Share by Country in 2019
Figure 47. Europe Oral Contrast Agent Revenue Market Share by Country in 2019
Figure 48. Germany Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Oral Contrast Agent Market Share by Type in 2019
Figure 59. Europe Oral Contrast Agent Market Share by Application in 2019
Figure 60. Asia Pacific Oral Contrast Agent Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Oral Contrast Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Oral Contrast Agent Sales Market Share by Region in 2019
Figure 63. Asia Pacific Oral Contrast Agent Revenue Market Share by Region in 2019
Figure 64. China Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Oral Contrast Agent Market Share by Type in 2019
Figure 87. Asia Pacific Oral Contrast Agent Market Share by Application in 2019
Figure 88. Latin America Oral Contrast Agent Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Oral Contrast Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Oral Contrast Agent Sales Market Share by Country in 2019
Figure 91. Latin America Oral Contrast Agent Revenue Market Share by Country in 2019
Figure 92. Mexico Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Oral Contrast Agent Market Share by Type in 2019
Figure 99. Latin America Oral Contrast Agent Market Share by Application in 2019
Figure 100. Middle East and Africa Oral Contrast Agent Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Oral Contrast Agent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Oral Contrast Agent Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Oral Contrast Agent Revenue Market Share by Country in 2019
Figure 104. Turkey Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Oral Contrast Agent Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Oral Contrast Agent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Oral Contrast Agent Market Share by Type in 2019
Figure 111. Middle East and Africa Oral Contrast Agent Market Share by Application in 2019
Figure 112. North America Oral Contrast Agent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Oral Contrast Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Oral Contrast Agent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Oral Contrast Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Oral Contrast Agent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Oral Contrast Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Oral Contrast Agent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Oral Contrast Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Oral Contrast Agent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Oral Contrast Agent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
診断用放射性医薬品・造影剤の世界市場（～2026年） Radiopharmaceuticals are a group of pharmaceutical drugs which have radioactivity. The contrast media plays an important role in enhancing the imaging facilities for better diagnosis. The market drivers are technology advancements in medical imaging, increasing demand for image guided procedures and…- 造影剤の世界市場（～2026年） A contrast agent is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast agents, enhance t…
- マイクロバブル/超音波造影剤の世界市場（～2026年） Microbubbles/ultrasound contrast agents are small spherical bubbles comprised of three phases, namely innermost gas phase, shell material enclosing the gas phase, and outermost gas or liquid phase. These microbubbles have unique ability to respond to ultrasound; thereby used for ultrasound imaging a…
- 磁気共鳴画像法（MRI）用造影剤の世界市場（～2026年） Market Analysis and Insights: Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Contrast …
- MRI造影剤の世界市場（～2026年） MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues …